Article info

Download PDFPDF
Pharmacological interventions
Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t)

Authors

  • Marco Solmi Neuroscience Department, University of Padua, Padua, Italy Neuroscience Centre, University of Padua, Padua, Italy PubMed articlesGoogle scholar articles
  • Christoph U Correll Psychiatry Research, Northwell Health, Zucker Hillside Hospital, Glen Oaks, New York, USA Hofstra Northwell School of Medicine, Hempstead, New York, USA The Feinstein Institute for Medical Research, Manhasset, New York, USA Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Marco Solmi, Neuroscience Department, University of Padua, Padova 35122, Italy; marco.solmi83{at}gmail.com
View Full Text

Citation

Solmi M, Correll CU
Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can’t)

Publication history

  • Received November 2, 2018
  • Revised December 21, 2018
  • Accepted December 25, 2018
  • First published January 21, 2019.
Online issue publication 
February 01, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.